1998
Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities
Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s37-s44. PMID: 9663622, DOI: 10.1097/00042560-199802001-00008.Peer-Reviewed Original Research
1995
'Dropouts' or 'drop-ins'? Client retention and participation in New Haven's needle exchange program.
Khoshnood K, Kaplan EH, Heimer R. 'Dropouts' or 'drop-ins'? Client retention and participation in New Haven's needle exchange program. Public Health Reports 1995, 110: 462-6. PMID: 7638334, PMCID: PMC1382156.Peer-Reviewed Original ResearchConceptsNeedle exchange programsNew Haven's needle exchange programStudy periodInjection drug usersSingle-visit groupCharacteristics of clientsMedian durationVisit groupClient participationDrug usersNeedle exchangeFull enrollmentSingle visitLonger durationExchange programsClient characteristicsYoung clientsThorough evaluationEnrollmentDurationNew HavenClient retentionYearsPercentRetention fraction
1994
A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?
Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange? American Journal Of Public Health 1994, 84: 1991-4. PMID: 7998644, PMCID: PMC1615375, DOI: 10.2105/ajph.84.12.1991.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation